Home › Idiopathic Pulmonary Fibrosis › Oregon › Portland
Idiopathic Pulmonary Fibrosis clinical trials in Portland, OR
3 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
RecruitingPhase 3
- The Oregon Clinic - Gateway Medical Office Location - Pulmonary, Critical Care & Sleep Medicine East, Portland
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Oregon Clinic, Portland
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
RecruitingPhase 2
- The Oregon Clinic Pulmonary East, Portland
Idiopathic Pulmonary Fibrosis trials in other cities
- Philadelphia, PA9 studies
- Birmingham, AL8 studies
- New York City, NY7 studies
- Los Angeles, CA6 studies
- Chicago, IL6 studies
- Kansas City, KS6 studies
- Durham, NC6 studies
- Aurora, CO6 studies
- Winston-Salem, NC5 studies
- Nashville, TN5 studies
- Houston, TX5 studies
- El Paso, TX5 studies
Other studies in Portland
- Non-Small Cell Lung Cancer49 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Ovarian Cancer28 studies
- Colorectal Cancer28 studies
- Lung Cancer27 studies
- Acute Myeloid Leukemia24 studies
- Endometrial Cancer24 studies
- Pancreatic Cancer19 studies
- Head and Neck Squamous Cell Carcinoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.